Mucopolysaccharidosis I [clinicaltrials_resource:3f6aa4e6287fb5bf722f1a3a2a4c5f0e]
Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation [clinicaltrials:NCT00005900]A Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG (Glycosaminoglycan) Levels in Aldurazyme® Treated Patients [clinicaltrials:NCT00144768]clinicaltrials:NCT00144781clinicaltrials:NCT00146757clinicaltrials:NCT00146770Stem Cell Transplant w/Laronidase for Hurler [clinicaltrials:NCT00176891]clinicaltrials:NCT00176917clinicaltrials:NCT00215527clinicaltrials:NCT00258011A Study of the Effect of Aldurazyme® (Laronidase) Treatment on Lactation in Female Patients With Mucopolysaccharidosis I (MPS I) and Their Breastfed Infants [clinicaltrials:NCT00418821]Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products [clinicaltrials:NCT00695279]clinicaltrials:NCT00741338clinicaltrials:NCT00748969Extension Study of Intrathecal Enzyme Replacement Therapy for MPS I [clinicaltrials:NCT00786968]clinicaltrials:NCT00852358clinicaltrials:NCT00912925clinicaltrials:NCT01586455Study to Detect Unrecognized Mucopolysaccharidosis in Children Visiting Rheumatology, Hand or Skeletal Dysplasia Clinics [clinicaltrials:NCT01675674]Mucopolysaccharidosis (MPS) I, II, and VI Screening in a High-Risk Population With Previous Surgical Repair or Presence of Inguinal and/or Umbilical Hernia in Combination With Pediatric ENT Surgery (The HATT Project) [clinicaltrials:NCT02095015]clinicaltrials:NCT02171104Extension Study of Intrathecal Enzyme Replacement for Cognitive Decline in MPS I [clinicaltrials:NCT02232477]Safety and Dose Ranging Study of Insulin Receptor MAb-IDUA Fusion Protein in Patients With MPS I [clinicaltrials:NCT02371226]
condition [clinicaltrials_vocabulary:condition]
Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation [clinicaltrials:NCT00005900]A Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG (Glycosaminoglycan) Levels in Aldurazyme® Treated Patients [clinicaltrials:NCT00144768]clinicaltrials:NCT00144781Mucopolysaccharidosis I (MPS I) Registry [clinicaltrials:NCT00144794]clinicaltrials:NCT00146757clinicaltrials:NCT00146770Stem Cell Transplant w/Laronidase for Hurler [clinicaltrials:NCT00176891]clinicaltrials:NCT00176917clinicaltrials:NCT00215527clinicaltrials:NCT00258011A Study of the Effect of Aldurazyme® (Laronidase) Treatment on Lactation in Female Patients With Mucopolysaccharidosis I (MPS I) and Their Breastfed Infants [clinicaltrials:NCT00418821]Intrathecal Enzyme Replacement for Hurler Syndrome [clinicaltrials:NCT00638547]Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products [clinicaltrials:NCT00695279]clinicaltrials:NCT00741338clinicaltrials:NCT00748969Extension Study of Intrathecal Enzyme Replacement Therapy for MPS I [clinicaltrials:NCT00786968]clinicaltrials:NCT00852358clinicaltrials:NCT00912925Administration of IV Laronidase Post Bone Marrow Transplant in Hurler [clinicaltrials:NCT01173016]Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders [clinicaltrials:NCT01372228]Laronidase (Aldurazyme TM) Enzyme Replacement Therapy With Hematopoietic Stem Cell Transplant for Hurler Syndrome [clinicaltrials:NCT01572636]clinicaltrials:NCT01586455Study to Detect Unrecognized Mucopolysaccharidosis in Children Visiting Rheumatology, Hand or Skeletal Dysplasia Clinics [clinicaltrials:NCT01675674]clinicaltrials:NCT01870375clinicaltrials:NCT01938014Mucopolysaccharidosis (MPS) I, II, and VI Screening in a High-Risk Population With Previous Surgical Repair or Presence of Inguinal and/or Umbilical Hernia in Combination With Pediatric ENT Surgery (The HATT Project) [clinicaltrials:NCT02095015]clinicaltrials:NCT02171104Extension Study of Intrathecal Enzyme Replacement for Cognitive Decline in MPS I [clinicaltrials:NCT02232477]clinicaltrials:NCT02298712Safety and Dose Ranging Study of Insulin Receptor MAb-IDUA Fusion Protein in Patients With MPS I [clinicaltrials:NCT02371226]clinicaltrials:NCT02437253
condition browse [clinicaltrials_vocabulary:condition-browse]
Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation [clinicaltrials:NCT00005900]A Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG (Glycosaminoglycan) Levels in Aldurazyme® Treated Patients [clinicaltrials:NCT00144768]clinicaltrials:NCT00144781Mucopolysaccharidosis I (MPS I) Registry [clinicaltrials:NCT00144794]clinicaltrials:NCT00146757clinicaltrials:NCT00146770Stem Cell Transplant w/Laronidase for Hurler [clinicaltrials:NCT00176891]clinicaltrials:NCT00176917clinicaltrials:NCT00215527clinicaltrials:NCT00258011A Study of the Effect of Aldurazyme® (Laronidase) Treatment on Lactation in Female Patients With Mucopolysaccharidosis I (MPS I) and Their Breastfed Infants [clinicaltrials:NCT00418821]Intrathecal Enzyme Replacement for Hurler Syndrome [clinicaltrials:NCT00638547]Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products [clinicaltrials:NCT00695279]clinicaltrials:NCT00741338clinicaltrials:NCT00748969Extension Study of Intrathecal Enzyme Replacement Therapy for MPS I [clinicaltrials:NCT00786968]clinicaltrials:NCT00852358clinicaltrials:NCT00912925Administration of IV Laronidase Post Bone Marrow Transplant in Hurler [clinicaltrials:NCT01173016]Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders [clinicaltrials:NCT01372228]Laronidase (Aldurazyme TM) Enzyme Replacement Therapy With Hematopoietic Stem Cell Transplant for Hurler Syndrome [clinicaltrials:NCT01572636]clinicaltrials:NCT01586455Study to Detect Unrecognized Mucopolysaccharidosis in Children Visiting Rheumatology, Hand or Skeletal Dysplasia Clinics [clinicaltrials:NCT01675674]clinicaltrials:NCT01870375clinicaltrials:NCT01938014Mucopolysaccharidosis (MPS) I, II, and VI Screening in a High-Risk Population With Previous Surgical Repair or Presence of Inguinal and/or Umbilical Hernia in Combination With Pediatric ENT Surgery (The HATT Project) [clinicaltrials:NCT02095015]clinicaltrials:NCT02171104Extension Study of Intrathecal Enzyme Replacement for Cognitive Decline in MPS I [clinicaltrials:NCT02232477]clinicaltrials:NCT02298712Safety and Dose Ranging Study of Insulin Receptor MAb-IDUA Fusion Protein in Patients With MPS I [clinicaltrials:NCT02371226]clinicaltrials:NCT02437253
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Mucopolysaccharidosis I [clinicaltrials_resource:3f6aa4e6287fb5bf722f1a3a2a4c5f0e]
Bio2RDF identifier
3f6aa4e6287fb5bf722f1a3a2a4c5f0e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3f6aa4e6287fb5bf722f1a3a2a4c5f0e
identifier
clinicaltrials_resource:3f6aa4e6287fb5bf722f1a3a2a4c5f0e
title
Mucopolysaccharidosis I
@en
type
label
Mucopolysaccharidosis I [clinicaltrials_resource:3f6aa4e6287fb5bf722f1a3a2a4c5f0e]
@en
Mucopolysaccharidosis I